Polyglycylation is a posttranslational modification that generates glycine side chains on proteins. Here we identify a family of evolutionarily conserved glycine ligases that modify tubulin using different enzymatic mechanisms. In mammals, two distinct enzyme types catalyze the initiation and elongation steps of polyglycylation, whereas Drosophila glycylases are bifunctional. We further show that the human elongating glycylase has lost enzymatic activity due to two amino acid changes, suggesting that the functions of protein glycylation could be sufficiently fulfilled by monoglycylation. Depletion of a glycylase in Drosophila using RNA interference results in adult flies with strongly decreased total glycylation levels and male sterility associated with defects in sperm individualization and axonemal maintenance. A more severe RNAi depletion is lethal at early developmental stages, indicating that protein glycylation is essential. Together with the observation that multiple proteins are glycylated, our functional data point towards a general role of glycylation in protein functions.
SUMMARY
Polyglycylation is a posttranslational modification that generates glycine side chains on proteins. Here we identify a family of evolutionarily conserved glycine ligases that modify tubulin using different enzymatic mechanisms. In mammals, two distinct enzyme types catalyze the initiation and elongation steps of polyglycylation, whereas Drosophila glycylases are bifunctional. We further show that the human elongating glycylase has lost enzymatic activity due to two amino acid changes, suggesting that the functions of protein glycylation could be sufficiently fulfilled by monoglycylation. Depletion of a glycylase in Drosophila using RNA interference results in adult flies with strongly decreased total glycylation levels and male sterility associated with defects in sperm individualization and axonemal maintenance. A more severe RNAi depletion is lethal at early developmental stages, indicating that protein glycylation is essential. Together with the observation that multiple proteins are glycylated, our functional data point towards a general role of glycylation in protein functions.
INTRODUCTION
Polyglycylation is a posttranslational modification that generates side chains of glycine on the g-carboxyl groups of specific glutamate residues of target proteins Vinh et al., 1999) . Similarly to polyglutamylation (Eddé et al., 1990) , this posttranslational modification was discovered on tubulin, where it occurs within the carboxy-terminal tail domains (Redeker et al., 1994) . While polyglutamylation was observed on many different types of microtubules (MTs), polyglycylation is particularly prominent in cilia and flagella and is mostly found in cells that possess these organelles (Bré et al., 1996; Levilliers et al., 1995) .
Functional experiments on tubulin glycylation were difficult to perform since the modifying enzymes were unknown. Initial insights into the potential function of polyglycylation were obtained using modification-specific antibodies. For example, anti-glycylation antibodies affected axoneme beating in vitro, suggesting that tubulin polyglycylation could regulate ciliary dynein (Bré et al., 1996) . In Tetrahymena, the elimination of the major glycylation sites on b-tubulin was lethal or led to severe axonemal defects, including short axoneme size, absence of the central pair MTs, and incomplete outer doublet MTs (Redeker et al., 2005; Thazhath et al., 2002; Xia et al., 2000) . Thus, tubulin glycylation could be an important regulator of both the assembly and functions of axonemal MTs. The recent observations that non-tubulin proteins are also substrates of polyglycylation (Ikegami et al., 2008; Lalle et al., 2006; Xie et al., 2007) indicate that glycylation is a posttranslational modification of general importance.
Here we describe the discovery of a group of enzymes that catalyze tubulin glycylation and show that some of these enzymes have non-tubulin substrates. We demonstrate that glycylases are members of the tubulin tyrosine ligase-like (TTLL) family, which already contains three types of known amino acid ligases, the tubulin tyrosine ligase (TTL; Ersfeld et al., 1993) , polyglutamylases (Janke et al., 2005; van Dijk et al., 2007; Wloga et al., 2008) , and an enzyme that ligates glycine to nucleosome assembly protein 1 (NAP1; Ikegami et al., 2008) . We show that in mouse, TTLL3 and TTLL8 proteins are initiating glycylases with different substrate specificities, whereas TTLL10 is the elongating polyglycylase. In mammals, cooperation of these two types of enzymes generates polyglycine side chains in mammals, whereas in Drosophila, bifunctional enzymes catalyze both reactions. We also demonstrate that the previously reported absence of long glycine side chains on human sperm tubulin (Bré et al., 1996) is caused by two inactivating amino acid substitutions in human TTLL10. Finally, we show by RNA interference (RNAi) that depletion of one of the two glycylases in Drosophila leads to strong reduction in polyglycylation, which causes defects in sperm maturation and results in male sterility. Moreover, expression of interfering RNA under a stronger promoter is lethal in early developmental stages. This suggests that polyglycylation is important for whole organism development in Drosophila. The identification of additional substrates of glycylation indicates that this modification could have a broad range of functions.
RESULTS

Identification of Murine Glycylases
Our study was initiated with the hypothesis that tubulin glycylases, like two other types of tubulin amino acid ligases, TTL (Ersfeld et al., 1993) and polyglutamylases (Janke et al., 2005; van Dijk et al., 2007) , are members of the TTLL protein family. Within the mammalian TTLL family, TTLL3, 8, 10, and 12 remained uncharacterized. According to phylogenetic studies, the TTLL12 gene is present in species that appear to lack glycylation (Janke et al., 2005; Schneider et al., 1997) , and murine TTLL12 has no glycylation activity in vivo and in vitro (K.R., unpublished data). In contrast, the presence of orthologs of TTLL3, 8, and 10 in genomes of diverse species (Janke et al., 2005) correlates with the known presence of tubulin glycylation, and a recent study showed that one of these three genes, TTLL10, encodes a glycylase for NAPs (Ikegami et al., 2008) .
To test whether mouse TTLL3, 8, and 10 have a tubulin glycylase activity, we expressed the respective cDNAs (van Dijk et al., 2007 ) in HEK293 cells and tested the cell extracts in an in vitro MT glycylation assay. To distinguish between two possible types of activities, initiation (addition of the first glycine to a g-carboxyl group of the target glutamate residue) and elongation of glycine side chains, we used substrates differing in the levels of tubulin glycylation: MTs polymerized from brain tubulin (that lack detectable glycylation) and strongly glycylated MTs of ciliary axonemes of Tetrahymena thermophila. Both TTLL3 and 8 promoted incorporation of [ 3 H]-glycine into brain MTs but had very low activity on axonemal MTs. In contrast, TTLL10 was almost inactive on brain MTs but promoted efficient [ 3 H]-glycine incorporation into axonemal MTs ( Figure 1A ). These observations suggest that TTLL3 and 8 are initiating glycylases, whereas TTLL10 is an elongating glycylase (polyglycylase) for tubulin. A similar functional specialization has been previously observed among polyglutamylases (van Dijk et al., 2007; Wloga et al., 2008) .
We also examined the selectivity of the enzymes for a-and b-tubulin. TTLL3 and 8 modified both a-and b-tubulin of brain MTs, with TTLL8 showing preference for a-tubulin ( Figure 1A ). For TTLL10, which modified only axonemal MTs, two-dimensional electrophoresis was used to separate axonemal a-and b-tubulin. Using anti-a-or b-tubulin antibodies as well as TAP952 (an antibody that recognizes monoglycylated sites on tubulins; Bré et al., 1998) , we found that both tubulin subunits of Tetrahymena axonemes are monoglycylated and thus are potential substrates for the elongation reaction. However, TTLL10 incorporated [
3 H]-glycine mainly into a-tubulin ( Figure 1B ). Next, we expressed TTLL3, 8, and 10 in U2OS cells and labeled the cells with antibodies that are specific to either mono-or polyglycylation: TAP952 and polyG (polyG specifically recognizes polyglycine chains; Duan and Gorovsky, 2002) , respectively ( Figure 1C ). Nontransfected U2OS cells show no reactivity with either of these two antibodies (arrowheads). After expression of TTLL3 or 8, we detected specific labeling of MTs with TAP952 but not with polyG. Thus, TTLL3 and 8 mediate initiation of glycine side chains on MTs in vivo but not side chain elongation. In contrast, cells expressing TTLL10 alone showed no labeling with TAP952 but had a diffuse labeling with polyG that did not correspond to MTs. This suggests that TTLL10 adds polyglycine chains directly onto proteins that are not associated with MTs, while it cannot modify MTs without prior monoglycylation.
Two-Step Glycylation Mechanism in Mammals
To test whether the two types of mammalian glycylases can function in a cooperative manner to create long side chains on MTs, we co-overexpressed either TTLL3 or 8 together with TTLL10 in U2OS cells. In both cases, we observed a strong labeling of MTs with the polyG antibody ( Figure 2A ). These results indicate that MTs have acquired polyglycine side chains, which was not the case when TTLL3, 8, or TTLL10 were expressed alone ( Figure 1C ).
On immunoblots, the monoglycylation-specific antibody TAP952 detected strong signals in the tubulin region upon expression of TTLL3 or 8 alone. Additional protein bands were labeled after TTLL8 expression, suggesting that TTLL8 can mediate glycylation of other non-tubulin proteins ( Figure 2B ). TTLL3 increased glycylation of mostly b-tubulin in U2OS cells, while it promoted modification of both a-and b-tubulin in the in vitro assay ( Figures 2B and 1A) . Thus, it appears that the substrate preferences of the glycylating enzymes change depending on additional factors. Neither TTLL3 nor TTLL8 alone generated polyG-reactive epitopes, indicating that they are indeed restricted to reactions that generate monoglycine side chains ( Figure 2B ). In contrast, no TAP952 labeling was detected in extracts of cells expressing TTLL10. However, a strong polyG signal was induced on two distinct protein bands, one of them the size of a-tubulin ( Figure 2B ). We demonstrate that the substrate in the tubulin region corresponds to NAPs. First, two-dimensional immunoblot analysis shows that the polyglycylated 50 kDa protein band superimposes with NAPs but not with tubulins ( Figure 2C ), and second, ectopically expressed NAP1-EYFP and NAP2-EYFP were strongly polyglycylated by TTLL10 ( Figure S1 available online). This is in agreement with the results of Ikegami et al. (2008) and indicates that in contrast to tubulins, NAPs can be polyglycylated directly by TTLL10.
After coexpression of TTLL3 or 8 with TTLL10, no TAP952 labeling was detected, whereas several protein bands were labeled with the polyG antibody. Virtually all protein bands labeled with TAP952 after expression of TTLL3 or 8 alone became labeled with polyG when TTLL10 was coexpressed ( Figure 2B ), suggesting that following monoglycylation by TTLL3 or 8, TTLL10 elongates glycine side chains of all major substrates of the initiating enzymes. The efficiency of this process is illustrated by the reduction of monoglycylated epitopes below detectable levels. This further indicates that the substrate specificity of polyglycylation in mammals is predetermined by the specificity of the initiating glycylases rather than by the specificity of elongating enzymes, except for proteins that are directly modified by TTLL10, such as the NAPs.
Loss of Elongating Activity in Humans
Human sperm axonemes, unlike sperm axonemes of several other mammalian species studied so far, have side chains limited to monoglycylation (Bré et al., 1996) . We confirmed this by comparing the status of glycylation in protein extracts prepared from mouse, rhesus monkey, and human sperm using the TAP952 and the polyG antibody ( Figure 3A) . Several mouse and rhesus protein bands were strongly labeled with polyG, while only weak signals were detected with TAP952. In contrast, human sperm proteins were not labeled with polyG but strongly with TAP952. No differences between the three species were found for the related tubulin modification, polyglutamylation ( Figure 3A , panel polyE).
To determine the molecular basis for the lack of elongated polyglycine chains in human sperm, we investigated the only known elongating glycylase in mammals, TTLL10. First, we confirmed the presence of a full-length mRNA by cloning TTLL10 from human testes cDNA. We then expressed human, mouse, and rhesus TTLL10 in U2OS cells. The mouse and rhesus TTLL10 generated polyglycylation that could be specifically detected with polyG, whereas the human protein was inactive ( Figure 3B ). Accordingly, when cell extracts from HEK293 cells overexpressing the respective TTLL10 proteins were used for in vitro assays, only the mouse and rhesus, but not the human, TTLL10 mediated incorporation of (C) Immunofluorescence analysis of U2OS cells overexpressing TTLL3-EYFP, TTLL8, or TTLL10-EYFP. TAP952 labels the MT cytoskeleton of cells expressing TTLL3 or 8 but not TTLL10. PolyG antibody detects a diffuse staining after TTLL10 overexpression. Nontransfected cells, visualized by DAPI staining of the nuclei, are labeled with neither TAP952 nor polyG (arrowheads). *TTLL8 was expressed as an untagged protein and detected with anti-TTLL8 antibody. Scale bar is 20 mm.
inactivating mutations to the central region of human TTLL10, which corresponds to the highly conserved core TTL domain (Figures S3, S4A, and S4B; van Dijk et al., 2007) . Within this domain, human and rhesus TTLL10 differ by 11 amino acids, out of which 4 are not evolutionarily conserved. Thus, we analyzed the remaining 7 amino acid changes by introducing them separately into the rhesus TTLL10. Two of these mutations led to a complete loss of polyglycylase activity (Figures S3 and S4C) , suggesting that the corresponding amino acids are essential for activity. When these two mutations in human TTLL10 were both reverted to the conserved amino acids found in rhesus and mouse, the enzyme recovered polyglycylase activity ( Figures 3D  and 3E ). This was not the case if only one mutation was reverted.
As neither of the two mutations has been found in the genomes of the great apes (not shown), it appears that humans are unique in having lost the polyglycylation activity of TTLL10. One of the two inactivating mutations (mut3) is polymorphic in the human population, leading to a high incidence (55.0% heterozygote and 16.7% homozygote) of TTLL10 alleles without mut3 in the subSaharan African population, whereas 91.7% of the European population are homozygous for the presence of mut3 (http:// www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1320571). No polymorphism was found for mut5. To investigate if the mut3 polymorphism could affect the enzymatic activity of TTLL10, we compared polyglycylation of sperm proteins from two homozygote individuals either with or without mut3 but both bearing mut5 ( Figure S5A ). The complete absence of polyglycylation on sperm proteins from both individuals ( Figure S5B ) confirmed that the presence of one of the two inactivating mutations is sufficient for the complete loss of enzymatic activity of human TTLL10 ( Figure S4C ).
In conclusion, we show that the human elongating glycylase TTLL10 is functionally inactive due to two mutations, resulting in the absence of polyglycylation in sperm. Considering that all known amino acid ligases that modify tubulin are members of the TTLL family, and that all TTLLs are expressed in testes (Ersfeld et al., 1993; van Dijk et al., 2007) , it is likely that TTLL10 is the only polyglycylating enzyme in mammals. Thus, humans could be a unique mammalian species that lacks protein polyglycylation.
Cancer-Associated Mutations Inactivate the TTLL3 Enzyme
In a recently published screen for putative cancer-associated genes, TTLL3 obtained a relatively high score as a potential cancer gene (Sjö blom et al., 2006) . It was striking that the two mutations identified in the screen were localized in the vicinity of the ATP-binding residue E662, which is essential for enzymatic activity in all TTLLs ( Figure 4A ; van Dijk et al., 2007) . To test the potential impact of these mutations, we introduced them separately into mouse TTLL3, which is identical to human TTLL3 in this region ( Figure 4A) , and tested the enzymatic activity of the mutated enzymes. Each cancer-related mutation led to a complete loss of glycylase activity of TTLL3 in vivo and in vitro ( Figures 4B-4D ), suggesting that reduction of monoglycylating activity could be related to cancer.
A Divergent Polyglycylation Mechanism in Drosophila
In mammals, TTLL10 appears to be the only enzyme able to elongate glycine side chains. However, in Drosophila, an organism with polyglycylated MTs (Bré et al., 1996) , only two orthologs of the TTLL3/8 group are present, whereas no TTLL10 gene has been found (Janke et al., 2005) . To establish the enzymatic mechanism that leads to the elongation of glycine side chains in the absence of TTLL10, we investigated the activity of the Drosophila melanogaster (dm) enzymes dmTTLL3A (CG11323) and dmTTLL3B (CG11201) in U2OS cells. Both enzymes induced monoglycylation on MTs ( Figure 5A , panel TAP952). Some cells expressing dmTTLL3B showed a restricted localization of this enzyme to the nucleus, and accordingly, only the nucleus was labeled with TAP952 in those cells ( Figure 5A, #) . However, in contrast to the mammalian orthologs ( Figure 1C ), dmTTLL3A also generated polyglycylated MTs as detected with polyG, while dmTTLL3B polyglycylated nuclear proteins but not MTs ( Figure 5A , panel polyG). Immunoblots revealed that dmTTLL3A initiates and elongates glycine side chains on a-and b-tubulin, whereas dmTTLL3B initiates glycylation on a number of proteins including a-tubulin but functions as an elongating glycylase only for non-tubulin substrates ( Figure 5B ). These polyglycylated substrates of yet unknown identity are likely to be responsible for the observed nuclear staining (Figure 5A ). Thus, Drosophila has a polyglycylation mechanism that utilizes bifunctional initiating/elongating glycylases.
dmTTLL3B Is Essential in Drosophila
Polyglycylation is particularly abundant in testes where it is associated with the axonemes of the sperm flagella (Bré et al., 1996; Bressac et al., 1995) . In Drosophila, one of the polyglycylase genes, dmTTLL3B, is highly expressed in testes ( Figure S6 ), suggesting that dmTTLL3B is the major polyglycylase in this organ. Thus, we attempted to deplete dmTTLL3B by RNAi, using a transgenic fly carrying inverted repeats that correspond to dmTTLL3B under the control of UAS sequences inducible by Gal4 (UAS-IR-dmTTLL3B transgene). Strikingly, 50% of the embryos carrying UAS-IR-dmTTLL3B and the ubiquitous da-Gal4 driver (dmTTLL3B da-RNAi ) did not survive to adulthood ( Figure 6A ).
RT-PCR analysis of adult dmTTLL3B da-RNAi flies demonstrated that dmTTLL3B inverted repeats were expressed and dmTTLL3B mRNA levels were strongly decreased. In contrast, mRNA levels of the closest homolog of this gene, dmTTLL3A, were unchanged ( Figure 6B ), demonstrating the specificity of the dmTTLL3B RNAi. Immunoblots of whole-protein extracts showed a strong reduction of polyG labeling on a range of protein bands in the dmTTLL3B da-RNAi flies ( Figure 6C ), whereas polyglutamylation levels were slightly increased in males but not in females ( Figure 6C , panel GT335). These data provide strong evidence that the majority of the protein polyglycylation in Drosophila is catalyzed by dmTTLL3B. Almost all adult male dmTTLL3B da-RNAi flies were sterile, as only 2.4% were able to generate offspring ( Figure 6D ), although with 20 times less progeny as compared to wild-type. This suggests that polyglycylation is important for spermatogenesis. (D) Immunoblot of U2OS cells expressing wild-type rhesus and human TTLL10, as well as human TTLL10 containing sequence reversions to amino acids present in rhesus and mouse TTLL10 (see Figure S3 ): S 448 N (rev3; reversion of mut3; see Figure S4C ), K 467 T (rev5; reversion of mut5; see Figure S4C ), or both of them (rev3+5). Wild-type rhesus TTLL10 and human TTLL10 carrying both rev3 and rev5 generated a strong polyG signal on NAPs, indicative of polyglycylase activity.
(E) Schematic representation of the human TTLL10 protein indicating the localization of the two amino acid reversions that allowed for reactivation of polyglycylase activity. The localization of the conserved core TTL domain (yellow) and the essential ATP-binding residue E511 are indicated (red; Figure S3 ; van Dijk et al., 2007).
The process of spermatogenesis in Drosophila can be divided into three major steps: (1) the generation of 64 haploid, interconnected spermatocytes from a stem cell, (2) the formation of the axonemes and the condensation of the sperm nuclei in the still interconnected spermatids, and (3) the individualization that resolves the syncytial sperm bundle into 64 separate sperm cells. This last step is achieved by a group of synchronously moving individualization complexes that remove excess cytoplasm and place the membranes around each cell. To determine which of the three steps were affected in dmTTLL3B da-RNAi flies, we analyzed the testes by immunofluorescence and transmission electron microscopy (TEM). In immunofluorescence (Figure 6E ) of wild-type testes, the polyG antibody stained prominent bundles of fibers that correspond to the sperm tails. The actin staining visualized groups of regularly arranged individualization complexes, which were always associated with the polyG-reactive MT bundles, confirming that sperm polyglycylation appears at the onset of individualization (Bré et al., 1996; Bressac et al., 1995) . In contrast, in dmTTLL3B da-RNAi testes, polyG staining was strongly reduced and actin cones were scattered along the tails, indicating a sperm individualization defect (Fabrizio et al., 1998) . Moreover, we observe that the tips of the testes were often enlarged in dmTTLL3B da-RNAi male flies ( Figure 6E ).
To better understand the observed defects, we used TEM to compare cross-sections of sperm cysts at different stages of maturity. In the preindividualization stage, sperm cysts of both control and dmTTLL3B da-RNAi flies appeared similar, as they contained the expected 64 sperm cells with an axoneme as well as a minor and a major mitochondrial derivate ( Figure 6F ). Upon maturation, sperm cysts become more compact due to strongly reduced cytoplasmic ground substance. At this late stage, control cysts were highly organized as each axoneme was positioned in the close proximity of a major mitochondrial derivate ( Figure 6G, panel control) . In contrast, most of the mature cysts from dmTTLL3B da-RNAi flies were lacking the axoneme structures, whereas the mitochondrial derivates were still present ( Figure 6G , panels dmTTLL3B
da-RNAi
). In some cases, disorganized axonemes composed of singlet MTs were found. We also observed rare cases of disorganized cysts that still contained axonemes but had reduced or absent mitochondria. Together our findings indicate that polyglycylation plays a role in individualization and is essential for the maintenance of the axoneme structure at later stages. However, it is not required for the early steps of Drosophila spermatogenesis, including the assembly of the axonemes.
Finally, we hypothesized that the initially observed partial lethality of the dmTTLL3B da-RNAi flies indicates an essential function of dmTTLL3B in Drosophila, and that the flies that reached adulthood survived due to the incomplete suppression of dmTTLL3B under the da-Gal4 driver. To test this hypothesis, we transgene (Dietzl et al., 2007) into the dmTTLL3B da-RNAi flies. Strikingly, we observed 100% lethality at the larval stage. This phenotype is not due to side effects of the UAS-Dcr-2 transgene (Dietzl et al., 2007) since the expression of UAS-IR-dmTTLL3B under the control of the very strong and ubiquitous Act5C-Gal4 driver also led to 100% lethality (not shown). Thus, in addition to an important role in spermatogenesis, dmTTLL3B-mediated polyglycylation could be essential for Drosophila development.
Identification of Candidate Substrates of Glycylation
The observation that mouse TTLL8 as well as Drosophila TTLL3B glycylate a range of non-tubulin proteins ( Figures 2B, 5B , and 6C) raised the possibility that glycylation is a posttranslational modification with a broad range of substrates. Following the observation that the two most prominent substrates of polyglutamylation, tubulins (Eddé et al., 1990) and NAPs (Regnard et al., 2000) , are also modified by polyglycylation (Redeker et al., 1994; Ikegami et al., 2008) , we hypothesized that additional substrates of glycylation are among the previously identified substrates of polyglutamylation . We expressed 12 potential substrates of polyglutamylation together with either TTLL8 or an enzymatically inactive (dead) version of TTLL8 in HEK293 cells. Five proteins (ANP32A, ANP32B, SET, RanGAP, and nucleolin) were found to be glycylated in the presence of active but not inactive TTLL8 (Figure 7 ). Seven other proteins tested (NF45, B23, GRP78, NASP, RNP-K, NCT, EB1; data not shown) were not modified. To uncover additional substrates by a more direct approach, we separated proteins from fly testes using two-dimensional electrophoresis and analyzed polyG-reactive proteins by mass spectrometry. We selected six of the identified proteins (Table S1 ; see Supplemental Data for more details) and co-overexpressed them with active or inactive TTLL8 in HEK293 cells. Among these proteins, troponin T was found to be specifically glycylated by ectopic TTLL8 (Figure 7) . The identification of a range of potential substrates of glycylation suggests that this modification could regulate the function of many proteins. Thus, the lack of glycylation of several proteins, and not only tubulin, could have contributed to the defects observed in the dmTTLL3B-depleted flies.
DISCUSSION
Polyglycylation was first described as a polymodification that generates glycine side chains of variable lengths on a-and b-tubulins (Redeker et al., 1994) . Similarly to polyglutamylation, it targets the C-terminal tails of tubulins, which are the major interaction sites for MT-associated proteins and molecular motors (Nogales, 2000) . Thus, polyglycylation could be an important regulator of MT functions. We have identified a group of enzymes that mediate the generation of glycine side chains on proteins. The glycylating enzymes are members of the TTLL family, which also contains other enzymes that catalyze amino acid ligations: tubulin tyrosine ligase (Ersfeld et al., 1993) and diverse polyglutamylases (Janke et al., 2005; van Dijk et al., 2007; Wloga et al., 2008) . Initiation and elongation of the glycine side chains are catalyzed by separate glycylases in mammals. Two initiating enzymes, TTLL3 and TTLL8, both generate monoglycylation on tubulin, whereas only TTLL8 modifies additional proteins. In agreement with our results, TTLL3 proteins in the ciliate Tetrahymena and in zebrafish are also initiating tubulin glycylases (Wloga et al., 2009 ). The subsequent elongation of glycine side chains in mammals is catalyzed by the elongating glycylase TTLL10.
The discovery of a strict two-step mechanism for MT polyglycylation in vertebrates raised two questions related to previous descriptions of polyglycylation patterns in different organisms. First, elongated glycine side chains are completely absent in human sperm tubulin (Bré et al., 1996) . We show that this phenotype is directly related to human TTLL10, which lacks enzymatic activity due to two point mutations in the conserved core TTL domain. It is striking that these mutations appear to be unique to human TTLL10, which suggests that the loss of polyglycylation was an event important for human evolution. Furthermore, the existence of a species devoid of polyglycylation suggests that the ''poly'' character of glycylation is not essential for protein functions, and that the functions of glycylation could be efficiently fulfilled by monoglycylation, which is present in all cilia in mammals (Dossou et al., 2007) . Another surprising observation was that Drosophila, an organism with reported polyglycine side chains on tubulin (Bré et al., 1996) , has no homologs of TTLL10. We show that in Drosophila, glycylases from the TTLL3/8 group act as bifunctional enzymes that are able to catalyze both initiation and elongation of glycine side chains, explaining why polyglycine side chains are present despite the absence of a TTLL10 ortholog. The two distinct glycylation mechanisms in mammals and Drosophila correlate with the previously described order of appearance of polyglycylation during sperm maturation. In mouse, polyglycine side chain elongation is delayed, appearing only after initial monoglycylation (Kann et al., 1998) , whereas in Drosophila, mono-and polyglycylation occur simultaneously (Bré et al., 1996) . In Drosophila the depletion of dmTTLL3B induced a significant decrease in glycylation, accompanied by decreased viability and an almost complete sterility of the surviving males. Detailed analysis of the dmTTLL3B da-RNAi flies revealed that the lack of dmTTLL3B affects late stages of spermatogenesis. This coincides with the timing of appearance of glycylation in Drosophila sperm development (Bressac et al., 1995) . We observed that although axonemes assemble, they become unstable and disassemble in the final stages of spermatogenesis. The disassembly of the axonemes is likely to proceed through a stage in which MT doublets are reduced to singlets, followed by the complete disappearance of all MT structures. Thus, one of the roles of glycylation in spermatogenesis appears to be the maintenance of the axonemal structure, whereas the modification is not required for the assembly. Due to their sensory role in cells, cilia are centers of signal transduction pathways involved in embryonic development and tissue homeostasis in adults. Therefore, defects in cilia can be related to cancer (Mans et al., 2008; Michaud and Yoder, 2006) . Our finding that two cancer-related mutations in TTLL3 (identified by Sjö blom et al., 2006) both completely inactivate this enzyme suggests that the lack of TTLL3 activity could affect cilia, which in turn could contribute to cancer progression.
The complexity of signals generated by polyglutamylation and polyglycylation on MTs could allow for different modes of regulation. Besides the possibility that both polymodifications generate signals for different target proteins, glycylation could also function as a counter-regulator of polyglutamylation, since both modifications compete for similar modification sites on tubulin (Redeker et al., 2005) . In agreement with this hypothesis, we show that tubulin polyglutamylation increases upon depletion of polyglycylation. Such a function could be sufficiently fulfilled by monoglycylation, which would help to explain the apparent lack of phenotypes related to the loss of elongated glycine side chains in humans.
Most of the past work on glycylation has been focused on the role of this modification in MT functions; however, several recent studies have shown that other proteins are substrates of glycylation (Ikegami et al., 2008; Lalle et al., 2006; Xie et al., 2007) . Together with our results, this opens the possibility that glycylation targets a broad range of substrates.
To conclude, we have identified a group of tubulin-modifying enzymes and two evolutionarily divergent mechanisms for glycine side chain initiation and elongation. Functional studies in Drosophila show that glycylation is important for sperm maturation, and that it might also be essential in early developmental stages in flies. Finally, the discovery that several important proteins could undergo glycylation raises the possibility that this modification acts as a general regulator of cellular functions.
EXPERIMENTAL PROCEDURES
Cloning and Mutagenesis
Mouse TTLL3, 8, and 10 have been identified and cloned before (van Dijk et al., 2007) . The rhesus monkey (Macaca mulatta) TTLL10 cDNA sequence was reconstructed from fragments found by NCBI Blast (http://blast.ncbi.nlm.nih. gov/) using known TTLL10 sequences as templates. The predicted sequence was amplified from testis cDNA (BioChain Institute Inc., USA) and cloned, and the DNA was sequenced. PCR-related mutations were excluded by sequencing of multiple clones (complete coding sequence: Figure S2A ). For human TTLL10, a splice variant ( Figure S2C ) of the sequence AK124125 has been amplified from testis cDNA (BioChain Institute Inc.) and verified by DNA sequencing. Drosophila dmTTLL3A (CG11323) and dmTTLL3B (CG11201) were cloned from cDNA from adult flies.
Point mutations were introduced by a PCR-based quick-change method. The presence of the mutation was verified by DNA sequencing.
Drosophila Genetics
Drosophila was grown on standard medium at 25 C. The w
1118
, UAS-IR-TTLL3B transgenic line was obtained from the Vienna Drosophila RNAi Center (http://www.vdrc.at). The transgene, localized on the X chromosome, expresses an inverted repeat from the dmTTLL3B gene (CG11201) under the control of UAS sequences. UAS-IR-TTLL3B flies were crossed with strains carrying the da-Gal4 (dmTTLL3B da-RNAi ) or the Act5C-Gal4 driver. For amplification of the RNAi effect, the da-Gal4 transgene was associated with the UASDcr-2 transgene (Dietzl et al., 2007) , and the resulting strain was crossed with UAS-IR-TTLL3B flies. For the viability test, 352 control (UAS-IR-TTLL3B) and 510 dmTTLL3B da-RNAi embryos were scored for survival to adulthood (results represented in Figure 6A ). Total RNA was extracted from adult flies with TRI-ZOL reagent (Sigma, USA), and reverse transcription was performed using the First-Strand cDNA synthesis kit (GE Healthcare, USA) with 5 mg of RNA and random hexamers as primers. 1/60 of this cDNA was used for PCR amplification. Primer pairs used for the detection of different gene transcripts can be provided on request. Number of PCR cycles used for dmTTLL3B: 30, dmTTLL3A: 35, rp49: 25. Male fertility was tested in individual crosses with w 1118 females, and the presence of progeny was scored after 2 weeks. Fifty-five individual crosses were scored for control (UAS-IR-TTLL3B) and 83 for dmTTLL3B da-RNAi males (results represented in Figure 6D ).
Isolation of Axonemes from
Tetrahymena Cilia CU427 Tetrahymena cells were grown in SPP medium (1% proteose peptone, 0.2% glucose, 0.1% yeast extract, 0.003% EDTA ferric sodium salt) at 30 C to mid-log phase (4-5 3 10 5 cells/ml). Cilia were collected as described (Brown et al., 1999) and stored at À80 C. For the preparation of axonemes, cilia were demembranated using 0.2% NP-40 in 13 ERB buffer (50 mM Tris/HCl, pH 8.0, 10% glycerol, 5 mM MgCl 2 , 1 mM EGTA). To remove the endogenous glycylase activity, axonemes were further treated with 1 M NaCl in 13 ERB for 30 min, followed by an incubation at 60 C for 20 min. Axonemes were spun down (12,000 g, 30 min, 4 C), and the supernatant was discarded. The pellet was then washed in 13 ERB and resuspended in 13 ERB at a final concentration of 5 mg/ml.
Tubulin Polyglycylation Assay
The enzymatic activity of glycylase was determined based on incorporation of [ 3 H]-glycine into MTs. The assay was performed in 50 ml of 13 ERB supplemented with 2 mM ATP and 250 pmol (5 ml) [ 3 H]-glycine (20.0 Ci/mmol; GE Healthcare). Enzymatic activity was measured using cell extracts prepared in 13 ERB containing 0.2% NP-40. Twenty micrograms of axonemal or taxotere-stabilized MTs (prepared from adult mouse brains as described; Regnard et al., 1999) were resuspended in the reaction mixture and immediately transferred to 30 C, followed by 4 hr of incubation. The samples were then subjected to SDS-PAGE (10% gels) and electrotransferred onto nitrocellulose membrane. The tubulin bands were visualized by staining with Ponceau S, cut out, and placed in 5 ml of scintillation liquid (Ultima Gold, Perkin Elmer, USA) for quantification. Affinity Purification of EYFP-Tagged Proteins EYFP-tagged potential substrates were coexpressed with TTLL8 in HEK293 cells. After lyses of the cells in PBS, 0.2% NP-40, the supernatant (100,000 g, 30 min, 4 C) was incubated with GFP-TRAP agarose beads (ChromoTek, Germany) for 4 hr at 4 C. Beads were washed twice in PBS, 0.2% NP-40 and boiled in Laemmli sample buffer for 5 min. The samples were spun at 20,000 g for 5 min and supernatants were analyzed by SDS-PAGE and immunoblot.
Protein Electrophoresis and Immunoblot
One-dimensional SDS-PAGE was performed using standard protocols, or a special protocol for the separation of mammalian a-and b-tubulin (Eddé et al., 1987) . Two-dimensional electrophoresis consisted of an isolelectric focusing step (IPGphor Isoelectric Focusing System; GE Healthcare) and an SDS-PAGE. For the resolution of the tubulin in Figure 1B , 40 mg of tubulin were loaded on 18 cm pH 4.5-5.5 Immobiline strips (GE Healthcare). Cell extracts shown in Figure 2C were prepared directly in the loading buffer (7 M urea, 2 M thiourea, 4% [w/v] CHAPS, 2% [v/v] IPG buffer [GE Healthcare], 40 mM DTT) and resolved in 8.5 cm pH 3.0-5.6 Immobiline strips (GE Healthcare). Membranes were incubated with the following antibodies: polyG (1:6000), polyE (1:1000; both courtesy of M. Gorovsky), TAP952 ascitic (F and G) After EYFP affinity purification, proteins were detected with anti-GFP antibody, and the level of glycylation was determined with TAP952. The total extract was probed for TTLL8 expression with anti-TTLL8 antibody.
fluid, 1:2000), 12G10 (Thazhath et al., 2002; 1:250) , E7 (Chu and Klymkowsky, 1989; 1:20) , 12CA5 (1:10), anti-GFP (1:5000; Torrey Pines Biolabs, USA), anti-NAP 4A8 (Fujii-Nakata et al., 1992; Ishimi et al., 1985; 1:20) . Antibodies against TTLL8 were raised in rabbits with bacterially expressed protein and then purified on recombinant TTLL8 and used at 1:500 dilution. Protein bands were visualized with HRP-labeled donkey anti-rabbit or antimouse IgG 1:10,000 (GE Healthcare) followed by detection with ECL immunoblot detection kit (GE Healthcare).
Immunofluorescence and Microscopy U2OS cells were cultured on glass coverslips under standard conditions and fixed using a protocol for preservation of cytoskeletal structures (Bell and Safiejko-Mroczka, 1995) . Fixed cells were incubated with TAP952 (hybridoma supernatant 1:200), polyG (1:3000), anti-TTLL8 (1:1000), or anti-GST (1:1000) antibody for 1 hr, followed by 30 min with anti-mouse or anti-rabbit Alexa 555 or Alexa 488 antibody (1:1000; Molecular Probes, USA). DNA was visualized by DAPI staining (0.02 mg/ml). Coverslips were mounted with MOWIOL. Drosophila testes were fixed for 30 min with 3.7% paraformaldehyde in PBS, permeabilized in PBS containing 0.5% Triton X-100, and incubated with polyG (1:9000) for 1 hr, followed by 30 min with anti-rabbit Alexa 647. Actin was visualized with TRITCconjugated phalloidin (1:10,000; Sigma). We used DMRA microscopes (Leica, Germany) and Metamorph (Universal Imaging Corp., USA) software.
For ultrastructural analysis, testes were isolated from 3-to 4-day-old male flies and fixed in 3.5% glutaraldehyde in 100 mM phosphate buffer (pH 7.4) overnight at 4 C. The samples were rinsed in phosphate buffer and post-fixed in 1% osmic and 0.8% potassium ferrocyanide for 2 hr in the dark at room temperature (RT). After rinsing in phosphate buffer, samples were dehydrated in a series of ethanol solutions (30%-100%) and embedded in EmBed 812 DER 736. Eighty-five nanometer sections were cut on a Leica-Reichert Ultracut E microtome and counterstained with uranyl acetate and lead citrate. Images were acquired with a Hitachi 7100 transmission electron microscope at the Centre de Ressources en Imagerie Cellulaire de Montpellier (France).
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